Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-06 4:00 pm Purchase | 13D | Akari Therapeutics Plc AKTX | Patel Samir Rashmikant | 5,745,834,167 10.850% | 2,332,672,000 (+68.34%) | View |
| 2024-10-25 4:28 pm Purchase | 13G | TUHURA BIOSCIENCES INC HURA | Patel Samir Rashmikant | 2,466,377 5.800% | 2,466,377 (New Position) | View |
| 2024-06-07 6:00 pm Purchase | 13D | Akari Therapeutics Plc AKTX | Patel Samir Rashmikant | 3,413,162,167 14.500% | 3,413,162,167 (New Position) | View |
| 2023-02-14 4:05 pm Purchase | 13G | Akari Therapeutics Plc AKTX | Patel Samir Rashmikant | 7,862,047 9.900% | 4,183,960 (+113.75%) | View |
| 2022-02-14 08:02 am Purchase | 13G | Akari Therapeutics Plc AKTX | Patel Samir Rashmikant | 3,678,087 6.200% | 1,185,701 (+47.57%) | View |
| 2021-02-16 08:31 am Purchase | 13G | Akari Therapeutics Plc AKTX | Patel Samir Rashmikant | 2,492,386 7.200% | 968,344 (+63.54%) | View |
| 2020-02-14 4:05 pm Purchase | 13G | Akari Therapeutics Plc AKTX | Patel Samir Rashmikant | 1,524,042 6.700% | 48,519 (+3.29%) | View |